Cambridge Nutritional Sciences PLC Scientific Educational Programme expanded
04 Décembre 2023 - 8:00AM
RNS Non-Regulatory
TIDMCNSL
Cambridge Nutritional Sciences PLC
04 December 2023
CAMBRIDGE NUTRITIONAL SCIENCES PLC
("CNS" or the "Company" or the "Group")
CNS continues to expand Scientific Educational Programme and
build relationships at leading Industry Events
-- Company delivers latest webinar tackling the role of inflammation in irritable bowel syndrome
-- Lecture presented in Dubai alongside one of India's key opinion leaders on food sensitivity
-- CNS continues to raise its profile at key industry events, helping drive demand for products
CNS (AIM: CNSL), the specialist medical diagnostics company
focused on promoting a personalised and functional approach to
health and nutrition, announces developments in its scientific
education programme, a key initiative which enables the Company to
collaborate with a number of global and UK-based key opinion
leaders in the nutritional science field. CNS also highlights the
industry events attended recently as it continues its drive to
build relationships with healthcare practitioners as well as
existing and prospective business partners.
Latest Educational Webinar Released: "Inflammation in irritable
bowel syndrome: myth or new treatment target"
-- Thought-leading topic exploring how food IgG antibodies can
activate mast cells in the gut leading to irritable bowel syndrome
symptoms.
-- In October, CNS's Scientific Director, Dr Nigel Abraham,
presented this lecture in person at the International Symposium for
food intolerance and Digestive Health ('FIDHC') in Dubai, alongside
Mumbai based Dietician and founder of FREEDOM Lifestyle and
Wellness Centre, nutrition advisor to the Indian Navy and key
opinion leader on food sensitivity testing in India, Dr Naaznin
Husein.
CNS Raises Awareness with Practitioners Through Networking at
Leading UK Industry Conferences
Key to CNS's strategy of maintaining a leadership position is
building awareness with healthcare practitioners. These events give
the company the opportunity to meet and re-engage with practitioner
customers as well as those who are new to food sensitivity testing
or taking their first steps in clinical practice.
IHCAN 2023 Summit
-- CNS's UK team participated in both the November and June
IHCAN 2023 summits, the UK's largest integrative health conference
and expo held in London.
-- Key industry event, attended by approximately 300 integrative
health practitioners and guest speakers from around the world.
-- Opportunity to explain the clinical utility for the Company's
products to future practitioners in the end stages of their
training.
-- Platform to educate those interested in learning about how
embedding food sensitivity testing in their practice can help
resolve gut related health issues and improve patient care.
NMI, IPMC, and ION
-- The company also attended several other relevant UK nutrition
conferences: Nutritional Medicine Institute ('NMI') in October, the
Integrative & Personalised Medicine Congress ('IPMC') in June
and the Institute for Optimum Nutrition ('ION') Open Day.
CNS Builds Business Partner Relationships at Industry Trade
Fair
Medica
-- In November the Company attended Medica in Germany. The event
allowed CNS to meet with existing business partners, whilst also
providing the opportunity to connect with potential new partners in
currently untapped territories for the Group.
Commenting, Jag Grewal, Chief Executive Officer, said:
"Collaboration with global and UK-based key opinion leaders in
the nutritional science field is one of CNS's core values and is a
fundamental part of our scientific education programme. As a
pioneer in personalised health and nutrition it is vital for us to
be leading the way with webinars exploring emerging aspects of
science related to gut health , and attending key industry events
alongside these high-profile speakers.
"This engagement is critical in our drive to foster strong
partnerships with healthcare practitioners and potential business
partners. It leads to better awareness and understanding of the
Company, which in turn creates demand for our products, and helps
cement the Group as a global thought leader in its field."
Contacts:
Cambridge Nutritional Sciences www.cnsplc.com
PLC
Jag Grewal, Chief Executive via Walbrook PR
Officer
Cavendish Capital Markets Tel: 020 7220 0500
Limited
Geoff Nash / Edward Whiley / George Dollemore
(Corporate Finance)
Nigel Birks / Harriet Ward
(ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus / Charlotte Edgar Mob: 07980 541 893 / Mob: 07884 664 686
/
Sam Allen Mob: 07502 558 258
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist
medical diagnostics company focused on industry-leading Health and
Nutrition products.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRANKDBNABDDFBK
(END) Dow Jones Newswires
December 04, 2023 02:00 ET (07:00 GMT)
Omega Diagnostics (LSE:ODX)
Graphique Historique de l'Action
De Oct 2024 à Oct 2024
Omega Diagnostics (LSE:ODX)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024